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judged particulady unfavorable with annual morality rates reported Up to 
6%o. However, prior studies were confined to pte referred to tertiary centers, 
selectively focused on high-risk assessment. To analyze natural history inde- 
pendent of such selection bias, we studied a cohort of 25 children identified 
with HCM from a community-based practice since 1972. Initially ages were 
0.5-18 yre (mean 6): 15 (60%) were male. Eight lots (32%) had basal out- 
flow obstruction with gradients 35-125 mm Hg; LV wall thicknesses were 
substantial, 10-40 rnm (mean 22), with a variety of patterns of left vantric- 
ular hypertrophy (LVH) evident. During foltow-up (1-21 yrs; mean 8), 4 pts 
died suddenly, aged 7-t9 yrs including 1 each after myofomy-myectomy or 
defibrillator implant. Each of the 4 tots with sudden death had massive LVH 
(wall thicknesses 40, 38, 31, 25 mm at ages 7, 7, 19, 10 years). Annual 
mortality rate was 2.0%; survival was 90% at 5 yrs. Eight surviving pts devel- 
obed limiting symptoms, including 4 who underwent myotcmy-myectomy. In 
conclusion: 1) HCM in childhood may be associated with substantial morbid- 
try/mortality; 2) dsk for youthful sudden death was substantially lower in this 
unestscted population represen~tive of the true disease state, than reported 
from referral canters; 3) massive LVH may be an independent dsk factor 
for sudden death in young children with HCM, suggesting the possibility of 
aggressive management for this patient subgroup, 
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~ Timing of Intervention for  Restrictive 
Cardiomyopathy In Children 
Rachel J. Wetter, Linda J. Addonizio, Maryanne R. Kichuk, Walton 
M. Gersony, Daphne 1". Hsu. Columbia Universit~, New York, NY 
Restrictive cardiomyopathy (RCM) is a rare entity characterized primarily 
by diastolic dysfunction leading to heart failure (HF). The timing of cardiac 
transplantation (CT) in children with end-2tage RCM has not been well 
defined. The mode of presentation, clinical course and outcome of 13 children 
(9 gifts, 4 boys) with RCM referred for CT were reviewed. Mean age at 
diagnosis was 4.6 yrs. (range 0.1-16 yrs.). The presenting symptom was 
HF in 4 pts, irregular heart rate in 3 lots, heart murmur in 3 pts, dyspnea 
in 2 pts, and syncope in 1 pt. A(I pts had evidence of diastolic dysfunction 
at presentation; 11113 children had preserved systolic function and 2 pts 
had poor systolic function. Significant atrial tachyarrhythmias occurred in 4 
lots (31%); 2 of these pts also developed complete heart block reouinng 
pacemakers. Major embslic events occurred in 2 pts (15%): stroke in 1 pt, 
pulmonary embolus in 1 pt. One lot developed a proteln-lasing entempathy. 
Two pts had unremitting HF from presentation; severe HF developed in the 
remaining 11 pts 3.3 yrs (range 0.3-8.5 yrs) following presentation. Cardiac 
catheterization performed at CT referral (2.8:1:2.4 yrs after presentation) 
demonstrated high filling pressures: LVEDP: 30 ± 9 romHg; RVEDP: 16 :E 
6 mmHg. The mean cardiac index was 2.2 -~ 0.38 IJmin/m2, The mean PA 
pressure was 50 :t: 20 mmHg with a mean pulmonary vascular resistance 
index (PVRI) of 10.8 (range 1.8--30). In 9 lots PVRI was >6 U/m2. The 
mean time to transplant or death in 12/13 pts was 7.3 :E 5 months after 
onset of HF. Four pts died of HF; 3 of these were not candidates for CT 
due to extremely elevated PVRI. CT was perf~,'med in 8 pts with 2 operative 
deaths from pulmonary hypertension and donor dght HF. In summary, HF 
developed late in 11113 (85%) children with RCM, but progressed rapidly. 
Severe pulmonary hypertension was present in 9113 pts (69%) at the time of 
cardiac transplant referral and precluded successful transplant in 5. Cardiac 
catheterization should be performed early In children with RCM to evaluate 
pulmonary vascular resistance and optimize the timing of transplantation. 
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~ Pediatric Dilated Cardlomyopathy (DCM): Prognosis 
in a Developing Nation Is Comparable to Developed 
Nations 
K. Kumar, D. TI1atsi, A. Saxons, V. Sdnivas, R. Juneja, S.S. Kothari, 
S. Shrivastava, S.E, Lipshuitz. Children's Hospital, Boston, MA; All India 
Institute of Medical Sciences, New Delhi, India 
Mortality from pediatric DCM is 3,3-67% 1-5 yrs after presentation i  studies 
from the US and UK. A Turkish study found 10% mortality over 2 yrs ot follow- 
up of 110 children with DCM. We determined prognosis of pediatric DCM in 
northern India where, compared to the US, 1) pediatric intensive care was 
more limited (e,g., 0.02 vs 1.84 PICU 10ecls/10O,gg0 population in northern 
India vs eastem MA), 2) PICU care was not as sophisticated, and 3) the 
average cost of admission for this diagnosis was less (usually < $200 US). 
128 consecutive children with DCM (77 males, 51 females, median age, 24 
mus, mean age, 46 rues, range, 2-180 rnos) were studied. Multivariate and 
survival analyses were performed on the 97 children with follow-up (mean, 23 
ads, range, 1-96 ads) and included sex, age at onset, delay after onset of 
symptoms, viral illness, CHF, ST-T changes, LVH, cardiothoracic ratio (CTR), 
LVER LA/AO, LV thickness/dimension. At presentation, CHF was noted in 
82% of pt~ and the mean LVEF was 0.41 ~ 0.15. 52 pts (54%) improved on 
therapy and of these, 23 (24%) became symptom-free without medication. 34 
pts worsened despite therapy, and 18 (19%) of these died. Deaths occurred 
within 3 yrs of follow-up. Multivariate analysis shewed tamats sex (RR: 
2.15; 95% CI: 1.07, 2.87), cardiomegaly on presenting CXR (RR for CTR 
> 0,68: 2.24, 95% CI: 1.04, 4.85), and LA enlargement at presentation (RR 
for LA/AO > 1.7: 2.02, 95% Ch 1.00, 4.22) as the variables associated 
with poor outcome (death/worsening). Female sex was the only significant 
univariate and multivariate predictor of death. Conclusions: The prognosis of 
pediatric DCM in northem India is at least comparable to those reported for 
pediatric DCM in developed nations. The prognosis of pediatric DCM may not 
improve without further understanding of its etiologies and the development 
of etioingy-specitic therapies. The developing female myocardium may be 
mere susceptible to damage than the male myocardium. 
4:45 
~- '~  Survival and Risk Factors for Death Alter Cardiac 
Transplantation in Infants: A Multi-lnatltutional 
Study 
Charles Center, David Naftet, Randall Caldwell, Richard Chinnock, 
EIfdeda Patti, Elizabeth Frezier, James Kirklin, Mark Boucak, 
Robert Morrow and the Pediatric Heart Transplant Study Group. Univ. of 
Atabama at Birmingham, B'ham, AL 35294 
Despite the increasing application of cardiac transplantation (C Tx) in infants, 
reported survival rates vary and risk factors for death are poorly understood. 
In order 1o examine early survival and risk factors for death in infants (<t yr 
of age) undergoing C Tx, 142 infants (36 < 1 me) undanNent primary C Tx 
from 1/1/93 to 1/1/95 at 21 canters in the Pediaffic Heart Transplant Study 
(PHTS). Diagnoses were hypoplastic left heart (66°/=), other congenital heart 
disease (170/o), cardiomyapathy (14%) and other (3%). 
Results: Actuarial survival after C Tx was 84% at 1 me, 70°/= at 1 yr, and 
69% at 2 yrs, with the greatest hazard for death in the first 3 ads. The 
principle cause of death was early graft failure in 20 pts (52% of deaths); 
infection in 10 (26% of deaths), and rejection in 4 (19%). The likelihood of 
death from early graft failure (or isolated right venfficular failure) was 130/o 
at 30 days. By multivadable analysis, risk factors for early mortality were 
history of previous stemotomy (p = 0.0003), recipient non-blood group A 
(p = 0.02), non-identical brood donor (p = 0.01), and donor cause of death 
other than closed head trauma (p = 0.04). Survival was favorable in idenfica', 
blood groups with no previous stemotomy (80°/= at I yr). Diagnosis at listing, 
waiting time (mean waiting time 1.3 me), graft ischemic time (range 68 to 
479 minutes, mean 228), and recipient icatropic support at listing were not 
predictive for mOrtality post C Tx. 
Inferences: 
• In the current era, strategies to improve donor heart function at implan. 
tation would have the greatest impact on survival after infant C Tx. 
• If early mortality from acute graft failure could be reduced by 75%, 
anticipated 1yr survival would approach 80°/,,. 
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J'7"6"7----~ Lelt Ventdcular Fill ing Psttems Predict Acute 
Rejection in Pediatric Heart Transplant Patients 
Douglas C. Sernler, Thomas R. Kimball, Sandra A. Wift. Children's HoSpital 
Medical Center, Cincinnati, Ohio 
Transplant rejection may effect LV diastolic function, Automatic border de- 
tection is a new echo techniql,e which continuously tracks the endocardium, 
allowing global assessment of LV filling. The aim of this study was to deter- 
mine if changes in LV tilling predict rejection in pediatric transplant pattsnts. 
Twelve patients (2-18 y.o.) had echoes at 2 study periods: 1) while healthy 
without rejection and 2) at biopsy-proven rejection. The percent of total LV 
filling due to rapid tilling (pRF), diaeresis (pO) and atrial contraction (pAC) 
were measured by automatic border detection from a parastemat raneveme 
view. Results: The percent of total LV tilling contributed by each diastolic 
phase is presented iP~ the pie charts below: 
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pRF decreased (p < 0.10) and pD increased significantly (p < 0.05) dudng 
rejection, pAC and heart rate did not change. 
We speculate that during rejection, inflammation i creases LV stiffness 
